August 9 (SeeNews) - Bulgaria's Financial Supervision Commission (FSC) said that it has approved the prospectus for admission to trading of a 5 million euro ($5.5 million) bond by local medical consumables distributor Bioiasis [BUL:BIOA] on the stock exchange in Sofia.
The bond placement comprises 10,000 freely transferable, secured, non-convertible bonds with a nominal value of 1,000 levs each maturing on April 6, 2031, the Financial Supervision Commission said in a statement on Tuesday.
The bonds have a floating rate based on the six-month Euribor plus 1.% but not exceeding 5.50% per year, the regulator added.
Bioiasis announced the bond issuance in April, seeking to raise funds to finance acquisitions, purchase receivables and repay liabilities.
($ = 0.9111 euro)